Diva Augusta Tavares Mendes
Research Subjects
Diva Augusta Tavares Mendes has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Anna Valerievna Krasnopolskaya
National Research Ogarev Mordovia State University
2 shared publications - Larisa Aleksandrovna Balykova
N.P. Ogarev Mordovia State University
2 shared publications - Anastasia M. Khanina
National Research Mordovia State University
1 shared publication M. G. Galkina
Children’s Republican Clinical Hospital
1 shared publication- Marina Vasilievna Shirmankina
National Research Ogarev Mordovia State University
1 shared publication - O. M. Soldatov
Children’s Republican Clinical Hospital
1 shared publication
Latest Publications
- 16 July 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (3) , 87-94
Iron deficiency anemia in children-athletes
The literature review focuses on iron deficiency anemia in young athletes is devoted. The main pathogenetic mechanisms of anemia’s development in athletes and differences in the main causes of its formation in athletes and in the population are demonstrated. The regulation mechanism of iron metabolism in the body, the effect of intensive physical load on this process are covered in detail, the effect of endogenous and exogenous iron on the level of physical performance is described. It describes the relationship between the nature of nutrition of athletes, sports specialization and the nature of training loads with the likelihood of developing anemia. A clinical example with the development of iron deficiency anemia in a teenager engaged in sports against the background of concomitant pathology is given. The importance of iron level control and prevention of iron deficiency anemia in young people engaged in professional sports is presented.
- 16 July 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (3) , 87-94
Iron deficiency anemia in children-athletes
The literature review focuses on iron deficiency anemia in young athletes is devoted. The main pathogenetic mechanisms of anemia’s development in athletes and differences in the main causes of its formation in athletes and in the population are demonstrated. The regulation mechanism of iron metabolism in the body, the effect of intensive physical load on this process are covered in detail, the effect of endogenous and exogenous iron on the level of physical performance is described. It describes the relationship between the nature of nutrition of athletes, sports specialization and the nature of training loads with the likelihood of developing anemia. A clinical example with the development of iron deficiency anemia in a teenager engaged in sports against the background of concomitant pathology is given. The importance of iron level control and prevention of iron deficiency anemia in young people engaged in professional sports is presented.
- Open Access
- 21 March 2025
- Published by National Research Mordovia State University MRSU in Medicine and Biotechnology
- Vol. 1 (1) , 13-23
Hypereosinophilic Syndrome: Contemporary Approaches to Molecular-Genetic Diagnostics and Gene-Engineered Biologic Therapy
Introduction. In recent years, there has been a growing interest among researchers in conditions associated with hypereosinophilia and the therapeutic potential of genetically engineered biological agents. Hypereosinophilic syndrome remains an insufficiently studied issue encompassing a spectrum of disorders characterized by persistent eosinophilia and eosinophilic involvement of internal organs. The aim of this study is to systematize scientific literature data on novel diagnostic and treatment approaches for hypereosinophilic syndrome.Materials and methods. A comprehensive analysis was conducted on research publications selected based on the keywords “hypereosinophilia”, “hypereosinophilic syndrome”, “molecular-genetic studies”, “idiopathic hypereosinophilic syndrome” and “monoclonal antibody” from a cohort of full-text articles available in the electronic scientific databases eLibrary, PubMed, and Scopus between 2005 and 2024.Results. The hypereosinophilic syndrome is a rare condition, with a limited number of scientific observations available in the literature, primarily consisting of analyses of individual clinical cases. Data on the prevalence of hypereosinophilic syndrome in the pediatric population are extremely scarce. The causes of the syndrome are variable, and the clinical presentation is polymorphic, complicating the diagnostic process. Molecular-genetic research, including the detection of tyrosine kinase gene mutation types, contributes to solving this issue. First-line treatment involves glucocorticosteroids. It has been shown that genetically engineered biological agents are more effective in the treatment of primary hypereosinophilic syndrome, with their pathogenetically justified use associated with therapeutic progress.Discussion and conclusion. The hypereosinophilic syndrome is more commonly observed in young and middle-aged patients. Diagnostic criteria include persistent hypereosinophilia with organ damage or dysfunction, as well as the exclusion of other myeloid neoplasms. The use of genetically engineered biologic agents enables overcoming refractoriness, reducing the need for glucocorticosteroids, and preventing the development of drug-related complications.
- 21 March 2025
- Published by National Research Mordovia State University MRSU in Medicine and Biotechnology
- Vol. 1 (1) , 13-23
Open AccessHypereosinophilic Syndrome: Contemporary Approaches to Molecular-Genetic Diagnostics and Gene-Engineered Biologic Therapy
Introduction. In recent years, there has been a growing interest among researchers in conditions associated with hypereosinophilia and the therapeutic potential of genetically engineered biological agents. Hypereosinophilic syndrome remains an insufficiently studied issue encompassing a spectrum of disorders characterized by persistent eosinophilia and eosinophilic involvement of internal organs. The aim of this study is to systematize scientific literature data on novel diagnostic and treatment approaches for hypereosinophilic syndrome.Materials and methods. A comprehensive analysis was conducted on research publications selected based on the keywords “hypereosinophilia”, “hypereosinophilic syndrome”, “molecular-genetic studies”, “idiopathic hypereosinophilic syndrome” and “monoclonal antibody” from a cohort of full-text articles available in the electronic scientific databases eLibrary, PubMed, and Scopus between 2005 and 2024.Results. The hypereosinophilic syndrome is a rare condition, with a limited number of scientific observations available in the literature, primarily consisting of analyses of individual clinical cases. Data on the prevalence of hypereosinophilic syndrome in the pediatric population are extremely scarce. The causes of the syndrome are variable, and the clinical presentation is polymorphic, complicating the diagnostic process. Molecular-genetic research, including the detection of tyrosine kinase gene mutation types, contributes to solving this issue. First-line treatment involves glucocorticosteroids. It has been shown that genetically engineered biological agents are more effective in the treatment of primary hypereosinophilic syndrome, with their pathogenetically justified use associated with therapeutic progress.Discussion and conclusion. The hypereosinophilic syndrome is more commonly observed in young and middle-aged patients. Diagnostic criteria include persistent hypereosinophilia with organ damage or dysfunction, as well as the exclusion of other myeloid neoplasms. The use of genetically engineered biologic agents enables overcoming refractoriness, reducing the need for glucocorticosteroids, and preventing the development of drug-related complications.